Global Obesity Treatment Surgery
Devices Market Research Report, by Type (Inactivity, Obesity gluten, Obesity),
Diagnosis (Blood Tests, Physical Examination), Treatment (Medication, Surgery,
Lifestyle Changes), End-Users (Hospitals, Clinics) - Global Forecast Till 2023
A comprehensive study of the
global Obesity
Treatment Surgery Devices Market is presented in the report, which takes a
look at the past and present of the Obesity Treatment Surgery Devices Market to
make projections about the market’s future growth trajectory. Key factors
involved in the market’s growth are examined in the report to enable readers to
understand their impact on the market in detail. Major drivers and restraints
affecting the global Obesity Treatment Surgery Devices Market are also studied
in the report to understand their relative impact on the market.
Obesity is the condition of
having excessive adipose tissue in the body. The cosmetic effects of obesity
are the primary consequence people consider when thinking about obesity,
however obesity is also related to several physical conditions. The presence of
obesity is linked to a higher risk of developing diabetes, cardiovascular
diseases, and more. Growing awareness about this risk has led to a growing
demand for obesity treatments in the last few decades. Over the last few
decades, obesity treatments have become more sophisticated due to developments
in medical technology and increasing understanding of the factors responsible
for obesity. The availability of noninvasive or minimally invasive obesity
treatments is likely to be a major driver for the Obesity Treatment Surgery
Devices Market, as liposuction or other invasive treatments of fat removal have
been the conventional course of treatment in the global Obesity Treatment
Surgery Devices Market. Increasing development of noninvasive obesity
treatments and the increasing awareness about the same is likely to be a major
driver for the Obesity Treatment Surgery Devices Market over the forecast
period.
On the other hand, high costs of
obesity treatments are likely to be a major restraint against the global
Obesity Treatment Surgery Devices Market over the forecast period. Surgeries
such as gastric banding can cost up to and more than USD 15,000, making them
too expensive for consumers in developing countries. However, the increasing
prevalence of obesity in developed countries is likely to be a key driver for
the global Obesity Treatment Surgery Devices Market over the forecast period.
Competitive Analysis:
Leading players in the global
Obesity Treatment Surgery Devices Market include Olympus Corporation, Covidien
plc, Mediflex Surgical Products, USGI Medical Inc., Medtronic, Johnson &
Johnson Services Inc., EnteroMedics Inc., Cousin Biotech, Allergan, Orexigen
Therapeutics Inc., Novo Nordisk A/S, F. Hoffman-La Roche Ltd., Arena
Pharmaceuticals Inc., and VIVUS Inc.
Research projects are likely to
be highly important for players in the global Obesity Treatment Surgery Devices
Market in the coming years. Development and commercialization of more efficient
and noninvasive obesity treatments is likely to remain a promising avenue for
players in the global Obesity Treatment Surgery Devices Market. Increasing
research into genetics is also likely to play a key role in the development of
the Obesity Treatment Surgery Devices Market over the forecast period.
In September 2019, researchers at
Texas Tech developed a nanocoating for reservatol, a chemical found in the skin
of grapes and some other berries. Reservatol enhances fat burning, but is
difficult to get into the adipose tissues in the first place, as it is acted
upon by the body’s digestive chemicals and broken down. The nanocoating
developed by the research team allows reservatol to reach the adipose tissues
easily, enabling high efficacy in fat burning.
Browse Complete Report: https://www.marketresearchfuture.com/reports/obesity-treatment-market-5872
Segmentation:
The global Obesity Treatment
Surgery Devices Market is segmented on the basis of type, diagnosis, treatment,
end use, and region.
By type, the global Obesity
Treatment Surgery Devices Market is segmented into inactivity obesity, food
obesity, anxiety obesity, venous obesity, atherogenic obesity, and gluten
obesity.
By diagnosis, the market is
segmented into blood tests, physical examination, and others.
By treatment, the Obesity
Treatment Surgery Devices Market is segmented into medication, surgery,
lifestyle changes, and others.
By end use, the market is
segmented into hospitals, clinics, pharmacies, and others.
Regional Analysis:
The Americas is likely to remain
the leading revenue generator in the global Obesity Treatment Surgery Devices
Market, followed by Europe and Asia Pacific. The increasing prevalence of
sedentary lifestyles in the Americas and the increasing consumption of junk
food is likely to be a major driver for the Obesity Treatment Surgery Devices
Market in the region.
No comments:
Post a Comment